All analyses
AI analysis

Co-operative Insurance Company PLC: research report

Moderately overvaluedneutralSep 2, 2026

June-quarter net profit rose 136.4% year-on-year as margins improved, but the share price has materially lagged the ASPI.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why balanced

  • June-quarter operating margin widened 5.1 percentage points to 9.1%.
  • Net profit rose 136.4% year-on-year to LKR 84.7 million.
  • The shares trade at 0.86 times book value, the lowest P/B position in the insurance peer group.

Against this. The share has fallen 27.7% over one year while the ASPI gained 3.0%.

Operating margin
9.1%sector 7.0%
from 4.1% a year earlier
Net margin
5.4%sector 4.1%
from 2.3% a year earlier, revenue +0.7%
Return on equity
4.4%sector 7.2%
full year to Dec 31, 2025
P/E
18.8sector 13.1
earnings Rs 0.17 per share
P/B
0.81sector 1.52
book Rs 3.97 per share
Dividend yield
0.00%sector 1.78%
trailing twelve months

Current figures, updated daily from filings to Jun 30, 2026. The report below was written on Sep 2, 2026. Sector figures are the median of 11 listed companies in the same sector.

Overview

Co-operative Insurance operates general and life insurance businesses through a nationwide cooperative-linked distribution network. The key recent change is a sharp recovery in June-quarter profitability despite broadly flat revenue, driven by stronger operating margins rather than top-line growth.

Price performance

COOP fell 15.0% over three months against a 4.2% decline in the ASPI, and its 27.7% one-year fall contrasts with a 3.0% index gain. The close was LKR 3.40 on 2 September 2026.

The price sits only 4.2% up from its 52-week low and 40.4% below its high. Trading has become quieter by its own standards: 60-day annualised volatility was 34.8% below the company's one-year level, while 20-day volume was 27.3% below the 60-day average. The share-price weakness is consistent with the reported tension between market performance and improved operating profitability, but the data does not establish its cause.

Valuation

At 14.58 times earnings, COOP is near the middle of the insurance group, at the 56th percentile of peers with P/E data. Its 0.857 times book value is the lowest P/B ranking in the peer set, but the latest audited return on equity was only 4.4%, limiting the case for a higher book multiple.

The stock has no indicated dividend yield. The recorded dividend was LKR 0.05 per share in FY2024, compared with LKR 0.135 in FY2021, while no intervening financial years appear in the payment record; the history therefore does not support treating the absent yield as a temporary shortfall.

News and sentiment

Direct coverage was normal rather than unusually loud, with three material articles in the past 90 days, all classified neutral. The 2 September disclosure concerned redemption of cumulative redeemable preference shares, while recent notices also covered board subcommittee changes and the appointment of a managing director and vice chairman.

A March report concerning the former chairman's contempt-of-court finding remains a governance consideration, although it falls outside the 90-day sentiment window.

Financials

June-quarter revenue increased 0.7% year-on-year to LKR 1.58 billion, while operating profit rose 126.9% and net profit rose 136.4% to LKR 84.7 million. Gross margin was 43.7%; the June 2025 gross-margin comparator is unavailable. Operating margin widened from 4.0% to 9.1%, and net margin rose from 2.3% to 5.3%.

The June operating and net margins ranked second among the respective four and five comparable June quarters on record, making the margin recovery strong on a like-for-like basis. Gross margin was middling, ranking third of six comparable quarters. Below-the-line items absorbed LKR 59.9 million of operating profit, so finance costs, tax and other non-operating items still took a substantial share of earnings.

Equity increased to LKR 6.56 billion from LKR 6.02 billion a year earlier. Shares outstanding were unchanged at 1.65 billion, so the improvement in per-share earnings was not mechanically caused by a change in share count. The latest audited full year ended December 2025, when revenue fell 4.3% but net profit grew 2.0%; it is not a current twelve-month measure.

Risks

The largest earnings risk visible in the latest quarter is the LKR 59.9 million gap between operating and net profit, which reduced conversion of underwriting and operating gains into earnings. This is especially relevant because revenue growth was only 0.7%, leaving profit progress dependent on the margin recovery.

Balance-sheet leverage appears modest on the latest audited data: total debt was LKR 591.7 million, equal to 9.3% of owners' equity, and operating profit covered finance charges 9.85 times. As an insurer, current-ratio and cash-conversion measures are not meaningful for assessing funding risk. Sector conditions also present uncertainty: as at 2 September 2026, falling Treasury and bond yields affect insurers' investment income and government-security valuations, while higher inflation can alter the claims and expense environment. Company-specific exposure to these factors is not supplied.

Outlook

As at 2 September 2026, the next defined event is the filing for the quarter ending 30 September 2026, expected between 12 November 2026 and 2 March 2027. That filing will show whether the June profit recovery persisted and will supersede the figures analysed here.

A dividend announced on 2 January 2026 remains undated, and the available scheduling data flags an older announcement as beyond its usual ex-date window. Its timing is therefore uncertain rather than confirmed. The data does not disclose the terms of the preference-share redemption or provide enough detail to quantify its financial effect.

About this report. Generated on Sep 2, 2026 from market data up to Sep 2, 2026, 3 material news articles over 90 days and financials to Jun 30, 2026. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports